Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment
暂无分享,去创建一个
J. Navarro-González | A. Dusso | J. Cannata-Andía | B. Martín-Carro | Isaac Tamargo-Gómez | C. Mora-Fernández | N. Carrillo-López | Sara Panizo | C. Alonso-Montes | L. Calleros | Noelia Avello-Llano | J. Martín-Vírgala | Sara Fernández-Villabrille | M. Naves-Diaz | Elena Astudillo-Cortés | Guillermo Mariño | Julia Martín-Vírgala | Elena Astudillo-Cortés | Guillermo Mariño
[1] Sha-Sha Li,et al. The controversy of klotho as a potential biomarker in chronic kidney disease , 2022, Frontiers in Pharmacology.
[2] Jinghong Zhao,et al. Renal Klotho safeguards platelet lifespan in advanced chronic kidney disease through restraining Bcl‐xL ubiquitination and degradation , 2022, Journal of thrombosis and haemostasis : JTH.
[3] T. Cheng,et al. Phosphate Metabolic Inhibition Contributes to Irradiation-Induced Myelosuppression through Dampening Hematopoietic Stem Cell Survival , 2022, Nutrients.
[4] Sha-Sha Li,et al. Abnormally decreased renal Klotho is linked to endoplasmic reticulum-associated degradation in mice , 2022, International journal of medical sciences.
[5] Sha-Sha Li,et al. Correlation Between Soluble Klotho and Vascular Calcification in Chronic Kidney Disease: A Meta-Analysis and Systematic Review , 2021, Frontiers in Physiology.
[6] A. Dusso,et al. The receptor activator of nuclear factor κΒ ligand receptor leucine-rich repeat-containing G-protein-coupled receptor 4 contributes to parathyroid hormone-induced vascular calcification. , 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[7] David A. Drew,et al. Performance of soluble Klotho assays in clinical samples of kidney disease , 2019, Clinical kidney journal.
[8] M. Motilva,et al. Barley-ß-glucans reduce systemic inflammation, renal injury and aortic calcification through ADAM17 and neutral-sphingomyelinase2 inhibition , 2019, Scientific Reports.
[9] Youhua Liu,et al. Wnt/β‐catenin/RAS signaling mediates age‐related renal fibrosis and is associated with mitochondrial dysfunction , 2019, Aging cell.
[10] W. Duan,et al. Lentiviral vector–mediated overexpression of Klotho in the brain improves Alzheimer's disease–like pathology and cognitive deficits in mice , 2019, Neurobiology of Aging.
[11] B. Timar,et al. Rapid decline of kidney function in diabetic kidney disease is associated with high soluble Klotho levels. , 2019, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.
[12] B. Nie,et al. Role of Wnt/β-Catenin Pathway in the Arterial Medial Calcification and Its Effect on the OPG/RANKL System , 2019, Current Medical Science.
[13] A. Dusso,et al. High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease. , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[14] M. Pollheimer,et al. Autophagy Protects From Uremic Vascular Media Calcification , 2018, Front. Immunol..
[15] M. Sánchez-Niño,et al. Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease , 2018, Diabetes Care.
[16] G. Bhagat,et al. Disruption of the beclin 1–BCL2 autophagy regulatory complex promotes longevity in mice , 2018, Nature.
[17] G. Bhagat,et al. Disruption of the beclin 1/Bcl-2 autophagy regulatory complex promotes longevity in mice , 2018, Nature.
[18] C. Giachelli,et al. Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho. , 2017, Bone.
[19] Javier A. Neyra,et al. Potential application of klotho in human chronic kidney disease. , 2017, Bone.
[20] D. Wheeler,et al. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) , 2017, Kidney international supplements.
[21] K. White,et al. Chronic Hyperphosphatemia and Vascular Calcification Are Reduced by Stable Delivery of Soluble Klotho. , 2017, Journal of the American Society of Nephrology : JASN.
[22] A. Webster,et al. Chronic Kidney Disease , 2017, The Lancet.
[23] E. Falk,et al. Limitations of the SCORE-guided European guidelines on cardiovascular disease prevention , 2016, European heart journal.
[24] M. Hu,et al. Klotho/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease , 2016, Kidney Diseases.
[25] A. Dusso,et al. Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease. , 2016, Kidney International.
[26] J. Cannata-Andía,et al. MicroRNAs 29b, 133b, and 211 Regulate Vascular Smooth Muscle Calcification Mediated by High Phosphorus. , 2016, Journal of the American Society of Nephrology : JASN.
[27] S. Sidhu,et al. Renal Production, Uptake, and Handling of Circulating αKlotho. , 2016, Journal of the American Society of Nephrology : JASN.
[28] M. Vervloet,et al. α-Klotho is unstable in human urine. , 2015, Kidney international.
[29] L. Hsiao,et al. α-Klotho Expression in Human Tissues , 2015, The Journal of clinical endocrinology and metabolism.
[30] M. Vervloet,et al. Shedding of klotho by ADAMs in the kidney. , 2015, American journal of physiology. Renal physiology.
[31] Kristien Daenen,et al. Microscopic nephrocalcinosis in chronic kidney disease patients. , 2015, Nephrology, Dialysis and Transplantation.
[32] A. Farcomeni,et al. Soluble α-Klotho Serum Levels in Chronic Kidney Disease , 2015, International journal of endocrinology.
[33] R. Gottlieb,et al. Untangling Autophagy Measurements: All Fluxed Up , 2015, Circulation research.
[34] Y. Nabeshima,et al. Reduced Renal α-Klotho Expression in CKD Patients and Its Effect on Renal Phosphate Handling and Vitamin D Metabolism , 2014, PloS one.
[35] J. Cannata-Andía,et al. Aluminum-Induced Osteogenesis in Osteopenic Rats with Normal Renal Function , 1999, Calcified Tissue International.
[36] G. Nadkarni,et al. Phosphorus and the kidney: What is known and what is needed. , 2014, Advances in nutrition.
[37] T. Yoo,et al. Circulating α-klotho levels in CKD and relationship to progression. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[38] Wei Zhu,et al. Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release. , 2013, Kidney international.
[39] Youhua Liu,et al. Loss of Klotho contributes to kidney injury by derepression of Wnt/β-catenin signaling. , 2013, Journal of the American Society of Nephrology : JASN.
[40] A. Di Napoli,et al. Diagnosis of Arterial Media Calcification in Chronic Kidney Disease , 2013, Cardiorenal Medicine.
[41] M. Kuro-o,et al. Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. , 2013, Annual review of physiology.
[42] R. Wüthrich,et al. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[43] Z. Massy,et al. Circulating Klotho levels: clinical relevance and relationship with tissue Klotho expression. , 2013, Kidney international.
[44] D. Fliser,et al. Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease. , 2013, Kidney international.
[45] M. Somerman,et al. High phosphate feeding promotes mineral and bone abnormalities in mice with chronic kidney disease. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[46] H. Nagasu,et al. Klotho protects against mouse renal fibrosis by inhibiting Wnt signaling. , 2012, American journal of physiology. Renal physiology.
[47] M. Kuro-o,et al. Characteristics of urinary and serum soluble Klotho protein in patients with different degrees of chronic kidney disease , 2012, BMC Nephrology.
[48] S. Devaraj,et al. Validation of an immunoassay for soluble Klotho protein: decreased levels in diabetes and increased levels in chronic kidney disease. , 2012, American journal of clinical pathology.
[49] O. Togao,et al. Klotho Inhibits Transforming Growth Factor-β1 (TGF-β1) Signaling and Suppresses Renal Fibrosis and Cancer Metastasis in Mice* , 2011, The Journal of Biological Chemistry.
[50] M. Kuro-o,et al. Klotho deficiency causes vascular calcification in chronic kidney disease. , 2011, Journal of the American Society of Nephrology : JASN.
[51] M. Kuro-o,et al. Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective. , 2010, Kidney international.
[52] M. P. Ruíz-Torres,et al. High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression. , 2010, Bone.
[53] Daniel J Klionsky,et al. In search of an “autophagomometer” , 2009, Autophagy.
[54] P. Saftig,et al. Klotho is a substrate for alpha-, beta- and gamma-secretase. , 2009, FEBS letters.
[55] G. Eknoyan,et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2006, Kidney international.
[56] K. Rosenblatt,et al. Regulation of Fibroblast Growth Factor-23 Signaling by Klotho* , 2006, Journal of Biological Chemistry.
[57] T. Ogihara,et al. Anti-apoptotic and anti-senescence effects of Klotho on vascular endothelial cells. , 2006, Biochemical and biophysical research communications.
[58] D. Prockop,et al. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. , 2004, Analytical biochemistry.
[59] E. Bonucci,et al. Renal Osteodystrophy in Predialysis and Hemodialysis Patients: Comparison of Histologic Patterns and Diagnostic Predictivity of Intact PTH , 2002, Nephron.
[60] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[61] A. Woolf,et al. Proliferation and remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesions. , 2001, The American journal of pathology.
[62] R. Ross,et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.